Immunovant, Inc.

Connor, Clark & Lunn Investment Management Ltd. IMVT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

467,469

Value ($000)

11,883

Weight

0.0%

2021 Q3 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	11,883	0.0%	467,469	12/31/2025
2025 Q3	11/13/2025	9,009	0.0%	558,897	9/30/2025
2025 Q2	8/7/2025	7,176	0.0%	448,515	6/30/2025
2025 Q1	5/12/2025	6,225	0.0%	364,229	3/31/2025
2024 Q4	2/10/2025	5,843	0.0%	235,884	12/31/2024
2024 Q3	11/8/2024	5,183	0.0%	181,799	9/30/2024
2024 Q2	8/9/2024	6,299	0.0%	238,588	6/30/2024
2024 Q1	5/9/2024	4,665	0.0%	144,385	3/31/2024
2023 Q4	2/9/2024	6,330	0.0%	150,240	12/31/2023
2023 Q3	11/13/2023	9,489	0.0%	247,182	9/30/2023
2023 Q2	8/10/2023	2,804	0.0%	147,804	6/30/2023
2023 Q1	5/10/2023	968	0.0%	62,383	3/31/2023
2022 Q4	2/10/2023	465	0.0%	26,219	12/31/2022
2022 Q3	11/10/2022	102	0.0%	18,352	9/30/2022
2022 Q1	5/12/2022	246	0.0%	44,668	3/31/2022
2021 Q4	2/10/2022	1,321	0.0%	155,041	12/31/2021
2021 Q3	11/12/2021	678	0.0%	78,051	9/30/2021